Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Cheson

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Blood|January 15, 1995
Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patientsG Tricot, S Jagannath, D Vesole, et al.
Blood|August 15, 1990
High-dose melphalan and granulocyte-macrophage colony-stimulating factor for refractory multiple myelomaB Barlogie, S Jagannath, D O Dixon, et al.
Blood|November 1, 1990
Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factorsS Jagannath, B Barlogie, K Dicke, et al.
Blood|August 1, 1996
Autotransplants in multiple myeloma: what have we learned?D H Vesole, G Tricot, S Jagannath, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemiaN Vey, H Kantarjian, H Tran, et al.
Blood|February 1, 1997
Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myelomaB Barlogie, S Jagannath, D H Vesole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1990
Chemotherapy is superior to sequential hemibody irradiation for remission consolidation in multiple myeloma: a Southwest Oncology Group studyS E Salmon, D Tesh, J Crowley, et al.
Blood|June 11, 1999
Sequential homoharringtonine and interferon-alpha in the treatment of early chronic phase chronic myelogenous leukemiaS O'Brien, H Kantarjian, C Koller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenous leukemiaH M Kantarjian, M Talpaz, T L Smith, et al.
Blood|October 26, 2000
Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatinI W Flinn, K J Kopecky, M K Foucar, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Blood|January 15, 1995
Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patientsG Tricot, S Jagannath, D Vesole, et al.
Blood|August 15, 1990
High-dose melphalan and granulocyte-macrophage colony-stimulating factor for refractory multiple myelomaB Barlogie, S Jagannath, D O Dixon, et al.
Blood|November 1, 1990
Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factorsS Jagannath, B Barlogie, K Dicke, et al.
Blood|August 1, 1996
Autotransplants in multiple myeloma: what have we learned?D H Vesole, G Tricot, S Jagannath, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemiaN Vey, H Kantarjian, H Tran, et al.
Blood|February 1, 1997
Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myelomaB Barlogie, S Jagannath, D H Vesole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1990
Chemotherapy is superior to sequential hemibody irradiation for remission consolidation in multiple myeloma: a Southwest Oncology Group studyS E Salmon, D Tesh, J Crowley, et al.
Blood|June 11, 1999
Sequential homoharringtonine and interferon-alpha in the treatment of early chronic phase chronic myelogenous leukemiaS O'Brien, H Kantarjian, C Koller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenous leukemiaH M Kantarjian, M Talpaz, T L Smith, et al.
Blood|October 26, 2000
Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatinI W Flinn, K J Kopecky, M K Foucar, et al.
Pageof 3